Cardiol Therapeutics Statistics

Total Valuation

TSX:CRDL has a market cap or net worth of CAD 152.90 million. The enterprise value is 134.85 million.

Market Cap	152.90M
Enterprise Value	134.85M

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CRDL has 82.65 million shares outstanding. The number of shares has increased by 18.77% in one year.

Current Share Class	82.65M
Shares Outstanding	82.65M
Shares Change (YoY)	+18.77%
Shares Change (QoQ)	+1.13%
Owned by Insiders (%)	3.67%
Owned by Institutions (%)	8.50%
Float	79.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	12.95
P/TBV Ratio	12.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.59
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.37

Financial Position

The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.01.

Current Ratio	2.46
Quick Ratio	2.30
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -276.41% and return on invested capital (ROIC) is -183.05%.

Return on Equity (ROE)	-276.41%
Return on Assets (ROA)	-108.74%
Return on Invested Capital (ROIC)	-183.05%
Return on Capital Employed (ROCE)	-337.69%
Revenue Per Employee	n/a
Profits Per Employee	-2.09M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.47% in the last 52 weeks. The beta is 0.79, so TSX:CRDL's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-32.47%
50-Day Moving Average	1.84
200-Day Moving Average	1.83
Relative Strength Index (RSI)	53.18
Average Volume (20 Days)	226,111

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.24M
Pretax Income	-37.55M
Net Income	-37.55M
EBITDA	-40.15M
EBIT	-40.24M
Earnings Per Share (EPS)	-0.48

Full Income Statement

Balance Sheet

The company has 18.20 million in cash and 142,554 in debt, giving a net cash position of 18.05 million or 0.22 per share.

Cash & Cash Equivalents	18.20M
Total Debt	142,554
Net Cash	18.05M
Net Cash Per Share	0.22
Equity (Book Value)	11.81M
Book Value Per Share	0.14
Working Capital	11.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -25.07 million and capital expenditures -32,408, giving a free cash flow of -25.10 million.

Operating Cash Flow	-25.07M
Capital Expenditures	-32,408
Free Cash Flow	-25.10M
FCF Per Share	-0.30

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:CRDL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.77%
Shareholder Yield	n/a
Earnings Yield	-24.56%
FCF Yield	-16.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2